| Title |
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)
|
|---|---|
| Published in |
Cancer Chemotherapy and Pharmacology, September 2007
|
| DOI | 10.1007/s00280-007-0599-0 |
| Pubmed ID | |
| Authors |
Fernando Rivera, M. Eugenia Vega-Villegas, Marta López-Brea, Dolores Isla, Marta Mayorga, Piedad Galdós, Antonio Rubio, Adolfo Del Valle, Fe García-Reija, Belen García-Montesinos, Julio Rodríguez-Iglesias, Jose Mayordomo, Julio Rama, Ramón Saiz-Bustillo, Jaime Sanz-Ortiz |
| Abstract |
We conducted a multicentric randomized phase II trial comparing 5-FU continuous infusion (PF) and cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy (IC) in locally advanced squamous cell head and neck cancer (LA-SCHNC). Primary objective was complete response (CR) to IC and overall survival (OS) was a secondary objective. |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Malaysia | 1 | 5% |
| France | 1 | 5% |
| Unknown | 18 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 5 | 25% |
| Student > Master | 3 | 15% |
| Researcher | 3 | 15% |
| Student > Bachelor | 3 | 15% |
| Lecturer | 1 | 5% |
| Other | 3 | 15% |
| Unknown | 2 | 10% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 65% |
| Biochemistry, Genetics and Molecular Biology | 1 | 5% |
| Nursing and Health Professions | 1 | 5% |
| Mathematics | 1 | 5% |
| Immunology and Microbiology | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 2 | 10% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2016.
All research outputs
#6,764,072
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#594
of 2,501 outputs
Outputs of similar age
#22,942
of 72,683 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#5
of 15 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,683 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.